The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease

Pediatr Rheumatol Online J. 2020 Mar 17;18(1):23. doi: 10.1186/s12969-020-0420-8.

Abstract

Background: The calcineurin and nuclear factor of activated T-cells (CaN-NFAT) signaling pathway had been found to be associated with Kawasaki disease (KD) susceptibility and coronary artery aneurysm formation as a contributor. To evaluate serum calcineurin (CaN) and nuclear factor of activated T-cells 1(NFAT1) levels in patients with Kawasaki disease (KD).

Methods: Serum levels of CaN and NFAT1 were measured by enzyme-linked immunosorbent assay method in 66 healthy children and 74 KD patients at acute, afebrile and subacute stage.

Results: The serum levels of CaN and NFAT1 increased significantly in the acute stage, and decreased progressively in the afebrile and subacute stage, along with the reduction of C-reactive protein, white blood cells and neutrophil counts. And in the acute stage, the afebrile stage and the subacute stage, the expression of CaN and NFAT1 was upregulated significantly in KD patients compared to that in the healthy control. After the IVIG treatment, the serum levels of CaN and NFAT1 declined significantly in IVIG responders. However, the CaN and NTAT1 levels in the IVIG non-responders declined slowly. And in the afebrile stage, the NFAT1 levels were lower in KD patients with coronary artery lesions (CALs) (268.82 ± 11.96 ng/ml) than those without CALs (285.84 ± 25.13 ng/ml). However, the serum levels of CaN in KD patients with CALs had no significant difference with those in KD patients without CALs.

Conclusions: The specific regulation of CaN and NFAT1 serum levels in the course of KD was suggested that both of them were related in the development of KD.

Keywords: Calcineurin; Coronary artery lesions; Kawasaki disease; Nuclear factor of activated T-cells.

MeSH terms

  • Calcineurin / blood*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Coronary Aneurysm / blood*
  • Coronary Aneurysm / diagnostic imaging
  • Coronary Aneurysm / etiology
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / etiology
  • Echocardiography
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Infant
  • Male
  • Mucocutaneous Lymph Node Syndrome / blood*
  • Mucocutaneous Lymph Node Syndrome / complications
  • Mucocutaneous Lymph Node Syndrome / therapy
  • NFATC Transcription Factors / blood*

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • NFATC Transcription Factors
  • NFATC2 protein, human
  • Calcineurin